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Abbreviations: 
Anatomic: 
 
IIn: optic nerve 
3dV: third ventricle 
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which should be cited to refer to this work.
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2A: amygdala 
AHA: anterior hypothalamic area 
Cer: cerebellum  
cp: cerebral peduncle  
DMH: dorsomedial hypothalamic nucleus 
DHA2: part of the dorsal hypothalamic area 
EP: entopeduncular nucleus 
fx: fornix 
GP: globus pallidus 
IHA1: part of the intermediate hypothalamic area 
I: infundibulum  
IP: interpeduncular fossa  
ISM: interstitial nucleus of the stria medullaris 
LHN1 and LHN2: part of the lateral hypothalamic nucleus 
LHN4: part of the lateral hypothalamic area 
LHAL: anterolateral subarea of the lateral hypothalamic area (Swanson, 2004) 
LHAav: lateral hypothalamic area, anterior region, ventral zone (Swanson, 2004) 
LHApc: lateral hypothalamic area, parvicellular region (Swanson, 2004) 
LHVL1: part of the ventrolateral subarea of the lateral hypothalamic area. 
LM: lateral mammillary nucleus 
LPOA4: lateral preoptic area 4 
MML: medial mammillary nucleus, lateral division 
MMM: medial mammillary nucleus, medial division 
MMP: medial mammillary nucleus, posterior division 
mfb: medial forebrain bundle 
mol: molecular layer of the lateral hypothalamus 
mt: mamillo-thalamic bundle 
mtt: mamillo-tegmental tract  
OB: olfactory bulb  
oc: optic chiasm  
on: optic nerve  
ot: optic tract 
P: pons 
PARH: para-arcuate hypothalamic nucleus 
ht
tp
://
do
c.
re
ro
.c
h
3PFX: perifornical nucleus 
POMA: magnocellular preoptic nucleus 
PV1: parvalbumin-positive nucleus of the lateral hypothalamus 
PV+d: parvalbumin-positive dendrite 
PV+t: parvalbumin-positive terminal 
RET: reticular nucleus of the thalamus 
SIL: sublenticular substantia innominata 
sm: medullary stria 
TUA: area of the tuber cinereum 
TUL: lateral tuberal nucleus (according to (Geeraedts et al., 1990a)) 
TUM1: part of the medial tuberal nucleus 
TUMM: tuberomammillary nucleus 
Type I: Gray type I synapse (asymmetric, excitatory) 
Type II: Gray type II synapse (symmetric, inhibitory) 
VMH: ventromedial hypothalamic nucleus 
ZI: zona incerta 
 
Neurotransmitters and neuromodulators: 
 
MCH: melanocorticotropic hormone 
5-HT: serotonin 
Gal: galanin 
NPY: neuropeptide Y 
NT: neurotensin 
TH: tyrosine hydroxylase 
 
Most anatomical abbreviations are taken from the work of Geeraedts and 
colleagues (Geeraedts et al., 1990a) (Geeraedts et al., 1990b) on the 
cytoarchitecture of the medial forebrain bundle. Some other abbreviations are 
from the atlases of Swanson (Swanson, 2004) and Paxinos (Paxinos and 
Watson, 2009). The PV1-nucleus is a term proposed to describe the 
parvalbumin-positive neuronal aggregate  described in this paper. 
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4ABSTRACT 
 
In the lateral hypothalamus, groups of functionally related cells tend to be widely 
scattered rather than confined to discrete, anatomically distinct units. However, 
using parvalbumin (PV)-specific antibodies, a solitary, compact cord of PV-
immunoreactive cells (the PV1-nucleus) has been identified in the ventrolateral 
tuberal hypothalamus in various species. Here we describe the topography, the 
chemo-, cyto- and myeloarchitectonics as well as the ultrastructure of this PV1-
nucleus in rodents. The PV1-nucleus is located within the ventrolateral division of 
the medial forebrain bundle. In the horizontal plane, it has a length of 1 mm in 
mice and 2 mm in rats. PV-immunoreactive perikarya fall into two distinct size 
categories and number ~800 in rats and ~400 in mice. They are intermingled with 
PV-negative neurons and coarse axons of the medial forebrain bundle, some of 
which are PV-positive. Symmetric and asymmetric synapses, as well as PV-
positive and PV-negative fibre endings, terminate on the perikarya of both PV-
positive and PV-negative neurons. PV-positive neurons of the PV1-nucleus 
express glutamate, not GABA - the neurotransmitter that is usually associated 
with PV-containing nerve cells. Although we could not find evidence that PV1 
neurons express either catecholamines or known neuropeptides, they sometimes 
are interspersed with the fibers and terminals of such cells. From its analogous 
topographical situation, the PV1-nucleus could correspond to the lateral tuberal 
nucleus in humans. We anticipate that the presence of the marker protein PV in 
the PV1-nucleus of the rodent hypothalamus will facilitate future studies relating 
to the connectivity, transcriptomics, and function of this entity. 
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5INTRODUCTION 
 
The hypothalamus contains a dense and complex interweaving of cell groups 
and fiber pathways that has defied for more than a century the attempts of 
neuroscientist to identify its many components.  Although the major cellular 
condensations in the medial hypothalamus were identified by (Gurdjian, 1927) 
and (Krieg, 1932), the lateral hypothalamic area (LHA) has proved much more 
difficult to subdivide.  Saper and colleagues (Saper et al., 1979) divided the LHA 
rostrocaudally into four divisions: the lateral preoptic area, and the anterior, 
tuberal, and posterior LHA.  These different rostrocaudal levels were found to 
have divergent patterns of projection as well.     
 The LHA is traversed by a longitudinal fiber pathway, the medial forebrain 
bundle, that connects the hypothalamus with the brainstem below it, and the 
basal forebrain and cerebral cortex above it. Veening and colleagues 
(Nieuwenhuys et al., 1982; Veening et al., 1982) divided the medial forebrain 
bundle into components based upon its myeloarchitecture and anterograde 
tracing from its known sites of origin.  These studies underscore the complexity 
of the fiber pathways that run through the LHA and why electrical stimulation of 
the lateral hypothalamic area causes alterations in such disparate activities as 
feeding, sexual behavior, aggression, vocalization, as well as blood pressure and 
heart rate (Chi and Flynn, 1971; Hess and Akert, 1955; Hoebel and Teitelbaum, 
1962; Lammers et al., 1988; Pfaff and Sakuma, 1979). The cellular bases for 
these responses are nearly impossible to interpret in such experiments.   
 The identification of chemically specified cell groups and their connections 
in the hypothalamus ushered in a new era in clarifying its structure and functions.  
For example, the identification of melanin concentrating hormone (MCH; 
(Bittencourt et al., 1992) and orexins (also known as hypocretins) (de Lecea et 
al., 1998; Sakurai et al., 1998), two peptide neurotransmitters that are expressed 
by neurons at the tuberal level of the LHA and in the dorsomedial and perifornical 
nuclei, has allowed identification of both discrete populations of neurons and their 
axonal pathways.  In addition, the availability of genetically driven methods for 
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6manipulating neuronal function (e.g., (Adamantidis et al., 2007) makes it tractable 
to study the function of chemically defined LHA cell populations.  Interestingly, 
these two cell populations and their projection pathways are interlaced at virtually 
all levels, so that it would have been very difficult to distinguish these neuronal 
populations and their distinct physiological activities (Hassani et al., 2010; Lee et 
al., 2005; Mileykovskiy et al., 2005), and functions in wake-sleep and feeding 
(Chemelli et al., 1999; Kokkotou et al., 2005; Sapin et al., 2010) without this 
chemical distinction.   
A great variety of neurotransmitters, neuropeptides, (Meister, 2007; Swanson, 
1987; Swanson et al., 2005) and receptors (Kilduff and de Lecea, 2001) have 
been localized in neurons of the lateral hypothalamus, especially in rats and mice 
(Berthoud and Munzberg, 2011). But the chemical phenotypes of some neurons 
in the lateral hypothalamus remain unknown.  An earlier publication (Celio, 1990) 
reported the presence of a continuous strand of parvalbumin-immunoreactive 
(PV-ir) neurons in the ventrolateral hypothalamus in rats.  As virtually nothing 
was known about the connections or functions of this cell group, in the present 
study we have endeavored to better characterize this cell group in both rats and 
mice, and to determine the nature of its afferents, using classical histology, 
immunohistochemistry and electron microscopy. 
 
MATERIALS AND METHODS 
Thirty-four adult Wistar rats [275-300g (Janvier SAS, Le Genest-St-Isle, France)], 
28 adult C57/Bl6 mice [20-30g (own breeding colony)] and 4 Balb-C mice [20-
30g (Pathology Unit, Fribourg)] of both sexes were used for this study. Animals of 
the same species (n=2 for each postnatal day) were euthanized 5, 6, 7, 8, 9, 10 
and 12 days after birth. In addition to the rodents, we examined sections from the 
brains of animals of other species which had been euthanized under deep 
sodium pentobarbital [Nembutal = sodium pentobarbital] anesthesia for a variety 
of unrelated reasons.  These included sections through the brains of bats (n=4, 
kindly supplied by Irmgard Amrein PhD, University of Zürich, Switzerland, 
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7experiments approved by the Veterinarian commission of the Canton of Zürich); 
cats (n=2, euthanized by Benoit Deillon, DVM, Bulle, for medical causes), guinea 
pigs (n=2, kindly supplied by Alexandre Babalian PhD, Physiology Dept. 
University of Fribourg, euthanized for neurophysiologic experiments approved by 
the Veterinary Commission of the Canton of Fribourg); and cynomologous 
monkeys (n=5, kindly supplied by Grazyna Wieczorek DVM, Novartis AG, Basel, 
euthanized for kidney transplantation experiments,  approved by the Veterinary 
commission of the Canton of Basel Stadt).  The overall study was approved by 
the Veterinary Commission for Animal Research of the Canton of Fribourg, 
Switzerland.  All animals were housed in state of the art animal facilities 
according to the strict Swiss animal testing law. In preparation for perfusion, the 
rodents were anaesthetized with a mixture of Ketalar [(Parke-Davis) 75 mg/kg of 
body weight] and Xylazine [(Streuli) 10 mg/kg of body weight]. A 0.9% saline 
solution followed by a 4% paraformaldehyde solution in 0.1M phosphate buffer 
(pH 7.4) were perfused through the left ventricle. The brains were excised and 
maintained in 18% or 30% solution of sucrose in phosphate buffered containing 
0.1% sodium azide for one day at 4°C. They were then frozen in pulverized dry 
ice. The specimens were cryosectioned into 40- or 80-m-thick sections and 
collected in 0.1 M phosphate buffer (pH 7.3). Immunofluorescence- and 
immunoperoxidase-staining techniques were conducted according to published 
protocols (Celio, 1990; Gerig and Celio, 2007). Briefly, free floating sections were 
first incubated with one of the primary antibodies to parvalbumin, which were 
used at dilutions of 1:5’000 - 1: 10’000.  All of the antibodies used are listed in 
Table 2, and their characterization is described in the next section. After 
treatment with a biotinylated secondary antibody, the sections were exposed 
either to streptavidin CY2, Cy3 or Cy5 (Jackson immunohistochemicals) for 
immunofluorescence or to the avidin-biotin-peroxidase complex (Vector 
laboratories, Burlingame, Ca, USA) for immunohistochemistry. This last complex 
was revealed using diaminobenzidine-hydrogen peroxide as the substrate. 
Immunostaining for PV was combined with that for well-characterized calcium 
binding-proteins, neuropeptides, neurotransmitters and catecholamines antisera. 
ht
tp
://
do
c.
re
ro
.c
h
8To stain the perineuronal net, Texas Red-conjugated Wisteria-floribunda lectin 
(WFA) was used (prepared by incubating the dye with the lectin at a 
concentration of 20 Pg/ml in TRIS-buffered saline (0.1 M, pH 7.3) containing 
0.1%Triton-X, 0.1mM MgCl2, 0.1mM MnCl2 and 0.1mM CaCl2).  
GAD-antibodies (gift of Dr. W. Oertel and acquired from Chemicon/Millipore) as 
well as monoclonal antibodies against GABA and glutamate (Swant Inc., Marly, 
Switzerland) crosslinked to albumin using glutaraldehyde (diluted 1:500) were 
dissolved in a solution of Na-pyrophosphate and Na-borohydride in TRIS-
buffered saline, together with mono- or polyclonal antibodies against PV [(Swant) 
1:500 dilution] and tested on free-floating, 40- m-thick coronal sections (Celio, 
1986b). The secondary antibodies were Alexa®-488-conjugated anti-rabbit IgG 
and Alexa®-567-conjugated anti-mouse IgG [(Invitrogen) diluted 1:500] for 4 
hours at ambient temperature.  
 
Antibody Characterization 
Antibodies against parvalbumin (235, PV28 and PVG214, all Swant Inc., Marly, 
Switzerland) recognize only one band of 12 Kda MW in Western blots of brain 
extract in various species, rat and mice included. They stain the brain in a pattern 
consistent with previous results (Celio, 1990) and do not produce staining in the 
brain of parvalbumin knock-out mice (Schwaller et al., 1999).  
Antibodies against calbindin D-28k (300, CB38, both Swant Inc., Marly, 
Switzerland) recognize only one band of 28 kDa MW on immunoblots of brain 
extract in various species, rat and mice included.  At very high antibody 
concentration CB38 may cross-react with calretinin. Both antibodies stain in a 
pattern consistent with previous studies (Celio, 1990) and are negative on the 
brain of calbindinD-28k knock-out mice (see product specification sheet of Swant 
Inc.). 
Calretinin antibodies (6B3, CR6797, both Swant Inc., Marly, Switzerland) 
recognize only one band of appropriate MW (29 KDa)  in an immunoblot of brain 
extract in various species, rat and mouse included. They are distributed in a 
pattern of cellular morphology and distribution as in previous studies (Rogers and 
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9Résibois, 1992) and do not stain the brain of calretinin knock-out mice (see 
product specification sheet of Swant Inc.). 
 
GAD-antibodies were kindly provided by Dr. Wolfgang Oertel (Oertel et al., 1981) 
or acquired commercially (Chemicon, now Millipore see Table ). These last react 
with a protein of the expected molecular weight in immunoblots of rat and mouse 
brain extracts and stain in a pattern consistent with results published by others 
(Mugnaini and Oertel, 1985; Wu et al., 1986).  
 
GABA (3D5, 3A12) and Glutamate monoclonal antibodies, antibodies (2D7), both 
of Swant Inc., Marly, Switzerland, were produced respectively against a 
glutaraldehyde-linked GABA- or glutamate-BSA conjugate (Liu et al., 1989; 
Matute and Streit, 1986). In dot blots they react with the appropriate aminoacid, 
do not cross react with other amino acids (Celio, 1986a) and in glutaraldehyde-
fixed tissue, their staining patterns are consistent with results by others using 
similar antibodies (Somogyi et al., 1985; Storm-Mathisen et al., 1983) (Seguela 
et al., 1984). 
 
Hypocretin / Orexin A (H-003-30) and B (H-003-32) antibodies were acquired 
from Phoenix Pharmaceuticals (Burlingame, Ca). They were produced against 
synthetic peptides with no crossreaction with similar peptides and their staining 
can be inhibited by absorption with the adequate antigen (1 Pg/Pl). Their staining 
pattern is consistent with previous localization results (de Lecea et al., 1998).  
 
Light microsocopy and quantification 
The sections were examined in either a Zeiss photomicroscope equipped for 
fluorescence with a SPOT-camera (Mod. 11.1), a Nikon 6000 photomicroscope 
equipped with a digital camera (DXM 1200) or a Leica confocal laser-scanning 
microscope (TCS Sp5 / DM 6’000). Brightness, contrast and evenness of 
illumination of the images were adjusted with Adobe Photoshop (CS4). 
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The numbers of neurons in the PV1-nucleus were counted on free-floating, 40-
Pm-thick horizontal serial sections through the brains of rats (Wistar: n= 6) and 
mice (C57Bl/6: n=6; Balb-C: n=4) of both sexes. All PV-immunoreactive neurons 
in which the nucleus (4 Pm) was visible in a DAPI-stain (Invitrogen) were counted 
with the aid of ImageJ software and the counts corrected by the method for 
estimation of the “true” cell number in the investigated brain area  (Guillery and 
Herrup, 1997) .  
 
Electron microscopy 
Rats were perfused with a solution of 4% paraformaldehyde. Coronal vibratome 
sections through the brain (50Pm in thickness) were exposed to PV-28 antibodies 
(Swant, Marly, Switzerland) for 72 hours at 4°C, followed by the avidin-biotin-
peroxidase technique. The specimens were postfixed in Karnovsky’s solution (a 
mixture of 2.5% glutaraldehyde and 2.5% paraformaldehyde) and then stained 
with 1% OsO4. After being embedded in Epon, the region containing the PV1-
nucleus was excised and affixed to an empty block of resin for sectioning. 
Inspection of the first 0.5-Pm-thick semi-thin section in the light microscope 
served to establish the orientation and topography of the PV1-nucleus. Ultrathin 
sections were then prepared using a Reichert ultramicrotome, stained with uranyl 
citrate and viewed in an EM-100 transmission electron microscope (Philips 
Biotwin CM100). 
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RESULTS 
Overview 
The PV1-nucleus is a bilateral, elongated condensation of cells, which extends 
longitudinally and almost horizontally through the lateral hypothalamus. This 
slender cord of cells has a length of approximately 2 mm in rats [spanning 
bregma levels -2.04 to -4.16 (Paxinos and Watson, 2009)] and approximately 1 
mm in mice [spanning bregma levels -1.15 to -2.18 (Franklin and Paxinos, 
1997).]. Three to ten PV-ir cells are visible in the  cross-section of the PV1-
nucleus. The best view of the PV1-nucleus is seen in horizontal sections, which 
reveal it to be sandwiched between the fornix medially, and the outer pial surface 
and the optic tract laterally (Fig. 1). Rostrally it fans out and coalesces with PV-
positive neurons in the magnocellular preoptic area. Caudally, the PV1-nucleus 
borders the lateral mammillary nuclei and the PV-immunoreactive 
tuberomammillary nucleus, from which it is clearly demarcated.  
Under conditions of dark-field illumination, the cross-sectioned PV-1 nucleus is 
revealed as a myelin-rich region (Fig. 2A). In sections that have been stained 
with Cresylviolet, only a small number of nerve cells can be discerned in the 
PV1-nucleus, which is barely recognizable as a discrete entity (Fig. 2B).  The 
dimensions of the PV1 cell group and the number of cells per section is similar to 
the A1 noradrenergic group in the medulla (see, e.g., (Tucker et al., 1987)). 
The number of PV-ir cells in the PV1-nucleus (counted bilaterally) amounts to 
850 +/- 45 cells in adult Wistar rats (n=6) and to 360 +/- 40 and 370 +/- 54 in 
adult Balb-C (n=4) and C57/BL6 mice (n=6), respectively. From time to time 
some animals show fewer cells in the PV1-nucleus, an as yet unexplained 
phenomenon. No right-left differences or sexual dimorphism is apparent on 
casual inspection, but our study was not powered to provide a meaningful 
statistical evaluation of these features.  
PV-immunoreactive cells are first discerned in the lateral hypothalamus during 
the second postnatal week, around day 6 +/-1 in rats and day 5 +/- 1 in C57 Bl/6 
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mice.  At the beginning the cells are roundish and in the adult become elongated 
or multipolar. 
In bats, guinea pigs and cats, a small collection of a few PV-ir neurons was 
observed in the region corresponding to the position of the PV1-nucleus in rats 
and mice (not shown). In rabbits, monkeys and humans, parvalbumin-
immunoreactive neurons were not detected in the ventrolateral region of the 
hypothalamus, which corresponds in position to the location of the PV1-nucleus 
in rats and mice.  
 
Precise localization of the PV1-nucleus 
In coronal sections, the position of the PV1-nucleus changes slightly in the 
rostrocaudal direction (Fig. 3A and 3B). It begins rostrally at the level of the 
anterior hypothalamic area, where it is located dorsolateral to the supraoptic 
nucleus, its coordinates in rats at this level are [-2.04mm from bregma (-1.15 in 
mice)], -8.8 mm from the dura (-4.8 in mice), and 2.2 mm from the midline (+/- 1.4 
in mice) (Fig. 3, B&B’). See also Table 1. Caudally, the PV1-nucleus in rats shifts 
slightly more medially, its coordinates at this level being -4.16 mm 
anteroposterially (-2.18 in mice); -8.8 ventral to the dura (-4.8 in mice) and +/- 2.0 
mm from the midline (+/- 1.1 in mice) (Fig. 3, D&D’; see also Table 1). The 
ventromedial bend in the PV1-nucleus occurs where the supraoptic decussation 
and the optic tract pass beneath the internal capsule, which extends to the lower 
surface of the brain (viz., to bregma levels -3.24 to -3.60 in rats). 
In coronal sections, four topographically distinct portions of the nucleus can be 
distinguished. The first lies just caudal to the medial preoptic area, lateral and 
cranial to the most lateral tip of the optic tract (3B, 3B’). The second portion is 
adjacent to the optic tract, which passes beneath the PV1-nucleus in a medial-to-
lateral direction (Fig. 3C & 3C’ and 3D & 3D’). The third portion lies in the angle 
formed between the optic tract and the internal capsule (Fig. 3E & 3E’). The 
fourth, more caudal and deepest portion sometimes bulges at the base of the 
brain (Fig. 3, F & F’). 
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Relationship of the PV1-nucleus to hypothalamic blood vessels 
The rostral, middle and caudal portions of the PV1-nucleus are either traversed 
by, or closely associated with blood vessels that penetrate the hypothalamus 
from the base of the brain (Figs. 1D, 3B’ and 6H).  
 
General morphology of the PV1-nucleus and its neurons 
In horizontal sections (Fig. 1) the PV1-nucleus appears as a strand of fairly 
compactly organized small and medium-sized PV-immunoreactive neurons, 
which lie amidst axons of the medial forebrain bundle, some of which are also 
PV-positive (Figs. 1C & 1D). The numerical density of cells is higher in the rostral 
than in the caudal part of the PV1-nucleus. Small neurons are encountered more 
frequently in the rostral and mid regions, and larger ones in the caudal part (Fig. 
1D). In sequential parasagittal and horizontal sections, and depending somewhat 
on the inclination of the slice, the PV1-nucleus has a fragmented appearance, 
although it is always distinguishable as a compact assembly of PV-
immunoreactive cells. In the PV1-nucleus, PV-immunoreactive neurons are often 
oriented horizontally and have a bi- or multipolar form. Their nuclei are large (6 
Pm diameter) and chromatin poor and show a distinct nucleolus (Fig. 4, A, B and 
D). The perikarya are either small (15-20 m in diameter) or middle-sized (25-30 
m in diameter). The smaller cells are usually bipolar (along the anteroposterior 
axis), whereas the larger ones are either fusiform or multipolar (Fig. 1, inset). The 
dendrites of the PV-immunoreactive neurons extend to the pial surface laterally 
and to the perifornical region medially. In the PV1-nucleus of mice, middle-sized 
neurons predominate over smaller ones. In both species, immunoreactivity for 
PV varies greatly in intensity; but, as a general rule, smaller cells tend to be less 
strongly stained than larger ones. PV-immunoreactive nerve fibers form boutons 
near PV-negative (Fig. 4 C, D) perikarya, irrespective of their size, but PV-ir 
boutons also form appositions along both the cell bodies and dendrites of PV-
positive neurons, usually the larger ones (Fig. 4 A & 7 E,F). Some PV-ir terminals 
on large cells may derive from small cells and vice versa, thus indicating 
intranuclear connections inside the PV1. The region of the PV1-nucleus that is 
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rich in PV-immunoreactive perikarya is characterized by a higher numerical 
density of PV-positive terminals (Fig. 4 A, C) and of variously sized axons 
emanating from the medial forebrain bundle (Fig. 1D). Fine PV-ir axons, which 
may stem from neurons in the PV1-nucleus, are sometimes seen to attain the 
pial surface or to course medially. However, most of the PV-immunoreactive 
axons leaving the PV1-nucleus proceed either rostrally or caudally via the medial 
forebrain bundle. Some of the axons leaving the PV1-nucleus proceed in a 
dorsolateral direction, following the course of the supraoptic decussation. 
 
Other markers of the PV1-nucleus 
We scanned a library of brains from previous studies for other neurotransmitters 
in the region of the PV-1 cell aggregate, but were unable to find evidence for the 
presence in that cell group of neurons immunoreactive for thyrotropin releasing 
hormone, orexin (Chou et al., 2003); galanin (Gaus et al., 2002); tyrosine 
hydroxylase, choline acetyltransferase, melanin-concentrating hormone, 
adenosine deaminase, histamine (Chou et al., 2002); dynorphin (Chou et al., 
2002); neurotensin, corticotropin releasing hormone, brain natriuretic peptide, 
somatostatin, enkephalin, (Moga and Saper, 1994); adrenocorticotropic 
hormone, D-melanocyte stimulating hormone (Moga et al., 1990); or 
endomorphin (Greco et al., 2008) (see also Fig. 5.). 
In particular, because PV is often seen in GABAergic neurons, we were 
especially surprised not to find any evidence for neurons that were 
immunoreactive for glutamic acid decarboxylase (Sherin et al., 1998) in the PV1 
cell region. The only potential neurotransmitter that we found in this area 
immunohistochemically was glutamate (Chou et al., 2003). 
We also looked for evidence of mRNA for these same neurotransmitters in the 
PV1 cell group, in both our own preparations for glutamic acid decarboxylase 67 
and galanin (Chou et al., 2003; Gaus et al., 2002), as well as in the Allen Brain 
Atlas database for the other markers we examined immunohistochemically, and 
of these only the vesicular glutamate transporter 2 (Chou et al., 2003) was 
present in region harboring the PV1 cell group.  
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We therefore did double-labeling for glutamate and for PV, and confirmed that 
nearly all of the PV-1 neurons are glutamatergic (see Fig. 6 A-C). Of the tested 
neuropeptide antisera, those against MCH and hypocretin-orexin A and B stained 
neurons in close vicinity to the PV1-nucleus, and some axon terminals ended in 
the cell cluster of the PV1 (Fig. 6D).  
Two other calcium binding proteins (calbindin D-28k and calretinin) are richly 
represented in the hypothalamus but generally avoid the PV1-nucleus. 
Nevertheless, some scattered bipolar cells that were immunoreactive for either 
CB or CR were found within the boundaries of the PV1 cell group (Fig. 6 E-F).   
Markers that are known to be associated with either the membranous 
cytoskeleton or the outer surface of PV-immunoreactive neurons in other parts of 
the brain were demonstrated also in the PV1-nucleus. These markers included 
those of the membranous cytoskeleton (Ankyrin-R and Spectrin-R) (not shown) 
and of the extracellular perineuronal net (the Vicia-villosa and Wisteria-floribunda 
lectins) (Fig. 6G).  
 
Ultrastructure of neurons in the PV1-nucleus 
At the ultrastructural level, the small neuronal perikarya of the PV1-nucleus 
exhibit an ovoid form. They possess an indented nucleus and are rich in rough 
endoplasmic reticulum. Perikarya and dendrites of PV-positive cells are involved 
in the formation of both symmetrical and asymmetrical synapses (Fig. 7A - 7 D). 
They are also contacted by PV-positive endings (Fig. 7 E, F). Some of these 
parvalbumin-positive terminals may emanate from neurons in the PV1, thus 
being intranuclear contacts. 
 
 
DISCUSSION 
 
The findings of the present study identify the PV-1 cell group as a clear 
cytoarchitectonic and neurochemical entity in rats and mice, although it could not 
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be detected in all species we have studied.   The PV-ir neurons are apparently 
glutamatergic, which is quite unusual for PV neurons in mammals.   
 
Comparison with previous studies 
The cell density of the PV1 nucleus, particularly the rostral part, is higher than 
that in the neighboring lateral hypothalamic area. Therefore, this cell group can 
be named as a „nucleus“, not like a part or just a cell group, or a subdivision of 
the lateral hypothalamic area, as described by those having recognized these 
cells previously (Bleier et al., 1979; Geeraedts et al., 1990b). 
In a series of landmark publications, Nieuwenhuys and his co-workers 
(Geeraedts et al., 1990a; Geeraedts et al., 1990b; Nieuwenhuys et al., 1982) 
reported on the existence within the lateral hypothalamus of a thick bunch of 
myelinated nerve fibers stemming from the medial forebrain bundle. Axons 
comprising the dorsolateral portion of this so-called “a-bundle” were postulated to 
derive from the olfactory tubercle, the magnocellular preoptic nucleus and the 
nucleus of the lateral olfactory tract, whereas those comprising its ventromedial 
portion were believed to stem from the anterior lateral hypothalamic area, the 
ventral part of the lateral septal nucleus and the nucleus of the diagonal band 
(Geeraedts et al., 1990a; Geeraedts et al., 1990b). 
Cytoarchitectonically, the region embracing the “a-bundle” was referred to by the 
same group of investigators as the ventrolateral subarea of the lateral 
hypothalamus (LHVL1) (Geeraedts et al., 1990a; Geeraedts et al., 1990b). 
Coronal and sagittal sections through the LHVL1 revealed the presence of a 
small and circumscribed cluster of cells – referred to as “nucleus-2” in single 
coronal and sagittal sections – which almost certainly corresponds to the middle 
portion of the PV1-nucleus described here (Fig. 3, A&A’). Swanson (Swanson, 
2004) name a somewhat larger rectangular volume the parvicellular region of the 
lateral hypothalamic area (LHAapc).  
PV-positive neurons are not scattered over the entire cross-sectional surface of 
the so-called “a” bundle, but are concentrated within its lower half. They 
represent only one – albeit a preponderant – subpopulation of nerve cells in the 
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PV1-nucleus. Rostrally, the PV-immunoreactive cord transgresses the 
boundaries of the LHVL (Geeraedts et al., 1990a; Geeraedts et al., 1990b; 
Nieuwenhuys et al., 1982) and coalesces with cells in the sublenticular 
substantia innominata and interstitial nucleus of the stria terminalis (Geeraedts et 
al., 1990a; Geeraedts et al., 1990b). In other atlases, this region coincides 
approximately with the magnocellular preoptic area (Paxinos and Watson, 2009), 
also called lateral hypothalamic area, anterior region, ventral zone (Swanson, 
2004). Caudally, the PV1-nucleus is confined to the LHVL1 and is clearly 
demarcated medioventrally from the  terete nucleus (Paxinos and Watson, 1999) 
and the mammillary nuclei. 
A cell group corresponding to the PV1-nucleus (Celio, 1990) now appears in 
atlases of the mouse (Hof et al., 2000) and rat brain (Paxinos and Watson, 
2009), albeit under another name – the preteretis nucleus – in the latter case. 
However, the PV1 runs parallel to the terete nucleus, and is clearly separated 
and cytoarchitectonically distinct from it.  
PV-immunoreactive nerve cells in cortical areas are often GABA-expressing 
interneurons (Celio, 1986b). However, the region of the lateral hypothalamus 
which embraces the PV1-nucleus has been observed to contain neither the 
GABA-synthesizing enzyme GAD (Mugnaini and Oertel, 1985) nor its mRNA 
(www.brain-map.org), even though GABA-positive axons terminate in the region. 
Given that PV-positive cells of the PV1-nucleus (i) manifest immunoreactivity for 
glutamate, (ii) probably express the mRNA for VGlut2 [according to the Allen 
Database (www.brain-map.org)], and (iii) are subject to retrograde filling with 
tracers injected into putative target areas in the midbrain (Celio and Saper, 
1999), it seems likely that most, if not all, of the PV-immunoreactive cells in the 
PV1-nucleus are glutamate-expressing projecting neurons. It remains to be 
ascertained if the large PV-positive neurons in the caudal part of the PV1-
nucleus project to the cortical mantle, as it has been shown for neuron of similar 
size and shape, located along the medial edge of the cerebral peduncle (Saper, 
1985). 
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Cytology, cytoarchitectonics and cell counting 
Our observations relating to the cytology and cytoarchitectonics of neurons in the 
PV1-nucleus accord well with the findings reported by Nieuwenhuys and his 
colleagues (Geeraedts et al., 1990a; Geeraedts et al., 1990b; Nieuwenhuys et 
al., 1982; Veening et al., 1982). We likewise observed a bipolar orientation of the 
smaller neurons and an increase in cell size rostrocaudally. In addition, we have 
reported (i) on the existence of two neurochemically distinct cell types (small and 
large PV-positive neurons as well as PV-negative ones), (ii) quantified the 
number of PV-immunoreactive neurons, (iii) and did not find evidence for right-
left asymmetry or sexual dimorphism in the numbers of PV1 neurons. The 
number of PV-immunoreactive neurons in the PV1-nucleus of rodents is about 
half of that estimated for hypocretin/orexin - expressing cells in C57/BL6 mice 
(Brownell and Conti, 2010; Gardi et al., 2008; Pinos et al., 2011).  
An age-dependent decline in the number of PV-immunoreactive neurons can be 
observed in the PV1-nucleus of mice between the 24th and 32nd postnatal months 
(www.brain-map.org). But further studies will be needed to ascertain whether this 
finding is attributable to a loss of immunoreactivity for PV or to the death of PV-
expressing neurons.  
 
Relationship of the PV1-nucleus to hypothalamic blood vessels 
The rostral end of the PV1-nucleus coincides with the level at which the small 
lateral hypothalamic vessels enter the hypothalamus (e.g. Fig. 6H). The vessels 
that are seen either to traverse or to pass close to the PV1-nucleus are probably 
the medial and posterior fascicular arteries and veins (Ambach and Palkovits, 
1979). But whether the relationship is of topographic interest alone or of 
physiological relevance remains to be clarified.  
 
Neurotransmitters, neuromodulators and calcium binding proteins 
We tested for more than 20 different putative neurotransmitters and 
neuropeptides in the PV1 neurons, but found only glutamate to be present.  
While it is possible that the use of colchicine injections might have identified 
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some other neurotransmitter in the PV1 cell group, the absence of anything but 
glutamate immunoreactivity in that population in intact rats and mice is quite 
striking.  MCH- and orexin-immunoreactive neurons were located very close to 
the PV1 (e.g. Fig 6G, H) but respected the boundaries of the PV1 field. In some 
cases immunoreactive axons, most notably for tyrosine hydroxylase, serotonin 
and cholecystokinin, coursed through the PV1-nucleus, and immunoreactive 
terminals formed appositions with PV1 neurons. Rare neurons positive for 
calbindin D-28k and calretinin mixed in with the PV1 group, but no colocalization 
with PV was observed (Figs. 6E-F). Orexin and MCH-positive neurons came 
close but neither occupied the field of the PV1, nor coexisted with PV in the same 
cell (Figs. 6D). 
 
Is the rat PV1-nucleus homologous to the human lateral tuberal nucleus? 
The lateral tuberal nucleus was described microscopically by Le Gros Clarke (Le 
Gros Clark, 1938) as a distinctive group of small neurons embedded in a 
gelatinous neuropil along the ventrolateral border of the hypothalamus in human 
brains.   These neurons were found to stain immunohistochemically for a variety 
of neuropeptides, including somatostatin, and corticotropin-releasing factor 
(Timmers et al., 1996).  A homologous-appearing structure has been identified in 
some non-human primates (Narkiewicz et al., 1994).  A lateral tuberal nucleus 
has not been identified in rodents (Gurdjian, 1927); (Krieg, 1932); (Franklin and 
Paxinos, 1997; Paxinos and Watson, 1999; Swanson, 2004). In more recent 
publications on the rat brain (Geeraedts et al., 1990a; Geeraedts et al., 1990b), 
the lateral tuberal nucleus has been depicted as a region lying dorsomedially to 
the LHVL, in which we localize the PV1-nucleus (TUL in their Fig 36; (Geeraedts 
et al., 1990b). In 1979 however, Bleier and her colleagues described on the basis 
of cytoarchitectonic criteria a “lateral tuberal nucleus” in the rat hypothalamus 
(Bleier et al., 1979) whose position corresponds to that of the PV1-nucleus. 
Indeed, at least the caudal part of the PV1-nucleus in rodents occupies a similar 
position to the lateral tuberal nucleus in monkeys (Fujii, 1982) and humans (Le 
Gros Clark, 1938). These observations raise the possibility that the lateral tuberal 
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nucleus in primates might be represented by the PV1-nucleus in rodents. 
However, the lateral tuberal nucleus in monkeys and humans lacks 
immunoreactivity for PV (Celio, unpublished observations), which cannot 
therefore be used as an argument in favor of a postulated homology. 
Nevertheless, phylogenic differences in the expression of calcium-binding 
proteins are not uncommon, the best known examples being the expression of 
calbindin D-28k and secretagogin in Meynert’s basal nucleus only in primates 
(Celio and Norman, 1985; Mulder et al., 2010). 
Hence, alternative criteria must be implemented to confirm or refute the 
postulated homology – perhaps an expression pattern for a common set of 
genes.   
 
Derivation and development 
In studies relating to the expression of Foxb1 in the developing ventral 
diencephalon, Alvarez-Bolado et al. (Alvarez-Bolado et al., 2000) identified 
patches of hypothalamic neuroepithelium that gave rise to neurons which migrate 
over long distances to colonize the ventrolateral nucleus of the lateral 
hypothalamic area (Geeraedts et al., 1990b). The authors remarked that the final 
destination of the labeled cells did not precisely coincide with any of the 
previously described hypothalamic nuclei, and they therefore referred to this 
niche for neurons as “Foxb1-expressing cells of the lateral hypothalamic 
nucleus”. The location of this cluster of Foxb1-expressing cells corresponds 
closely to that of the rodent PV1-nucleus (compare their figures 3A and 4A with 
our Fig. 1C). Although Foxb1 is expressed mainly by large neurons on the 21st 
postnatal day, it is absent from the nerve cells of adult animals (www.brain-
map.org). It would therefore be interesting in the future to determine if the Foxb1 
neurons also express PV in young animals.  Alternatively, a Foxb1-Cre mouse 
could be crossed with a green fluorescent protein (GFP) reporter mouse, 
producing permanent staining of the transiently Foxb1-positive neurons.  This 
would allow localization of the GFP with respect to parvalbumin, and could aid in 
tracing the projections of these neurons. 
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PV-ir cells are first discerned in the PV1-nucleus of rodents around the 6th 
postnatal day, concomitant to their colonization of the cerebral cortex. In the 
Allen Brain Atlas, the expression of PV is discerned between the 7th and the 21st 
postnatal days. Immunoreactivity for hypocretin, on the other hand, appears in 
the lateral hypothalamus on about the 15th postnatal day (Yamamoto et al., 
2000).  
 
Possible functions of the PV1-nucleus 
Although the LHA has been implicated in older electrical stimulation or lesion 
studies in a wide range of behaviors, from regulation of sleep (Arroyo et al., 
1993; Economo, 1930; Jurkowlaniec et al., 1996), to feeding (Delgado and 
Anand, 1953; Turenius et al., 2009), and blood pressure control (Hess, 1981; 
Spencer et al., 1989), it is difficult if not impossible to determine whether the PV1 
neurons played a role in these responses. Similarly, while the sites used for 
classical studies on intracranial self-stimulation were also nearby (Olds and 
Fobes, 1981), it is difficult to know whether PV1-neurons were activated during 
intracranial self-stimulation, let alone playing a role in sustaining it. 
In the history of hypothalamic research, clinical observations on patients have 
often prepared the ground for understanding the role of various parts of this 
intricate brain region. Adiposogenital dystrophy (Fröhlich, 1901), due to a tumor 
in the region of the arcuate nucleus foreshadowed the role of this nucleus in the 
control of appetite. Narcolepsy is explained today as a disorder of loss of 
signaling by  hypocretin/orexin neurons (Saper et al., 2010). Within or close to 
the lateral wall of the tuberal region of the human hypothalamus hamartomas 
arise and lead to gelastic (laughing) seizures (Arroyo et al., 1993; Kuzniecky et 
al., 1997; Valdueza et al., 1994).  The lateral hypothalamus has also been 
implicated in the proper functioning of the larynx (Arita et al., 1995) and the 
trachea (Tatsuta and Arita, 1996) and in the control of vocalization (Burgdorf et 
al., 2007).  The neurons that compose hypothalamic hamartomas have been 
found to be mainly GABAergic and many contain gonadotropin-releasing 
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hormone (Chan et al., 2010), so they are not likely to arise from the PV1 cell 
group.  However, tumors in this region may potentially irritate a human 
homologue of the PV1-nucleus.  It is therefore tempting to suppose that the PV1-
nucleus may be involved in primitive forms of vocalization, found also in rodents 
(Panksepp and Burgdorf, 2003). Perhaps genetically-driven electrophysiological 
or optogenetic methods that are defined by the presence of parvalbumin in the 
nucleus may provide a way to test this hypothesis. 
 
Nowadays, it is rare to discover aggregates of nerve cells with a common 
biochemical signature in the brain. Assuming that each brain nucleus has a 
specific role to play, the search for a possible functional implication of the 
hypothalamic PV1-nucleus becomes a thrilling challenge. 
 
 
FIGURE LEGENDS 
Fig. 1 
Topography of the PV1-nucleus in the lateral hypothalamus 
A: Ventral view of a perfusion-fixed rat brain. The approximate location of the 
PV1-nucleus is highlighted with two red stripes and indicated with an arrow. See 
list of abbreviations. Scale bar: 1 mm. 
 
B: Schematic tracing of a horizontal section at the level of the PV1 nucleus, 
reproduced in modified form from (Geeraedts et al., 1990b). For abbreviations 
see table 1. The projected full extent of the PV1 nucleus is highlighted in blue. 
The contour of the PV1 at this level (compare with Fig. 1C) is given by the 
stippled red line.  
 
C: Horizontal section through the rat hypothalamus at a depth of 8.4 mm 
(Paxinos and Watson, 2009). The PV1-nucleus is oriented parallel to the fornix 
(fx), located medial to the optic tract (ot) and separated from the brain surface by 
the molecular layer (mol). The PV1-nucleus – outlined with a broken white line – 
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is here seen to contain a large number of PV-immunoreactive neurons. The 
anterior part is rich in small-, the posterior in large neurons (see also Fig. 1D). 
See list of abbreviations. Scale bar: 1 mm. 
 
D: Higher-magnification view of the PV1 from another experiment 
(immunoperoxidase staining). In this horizontal plane of section the distinction 
between the rostrally located, smaller PV-positive neurons (S) and the larger 
neurons located distally (L) is well visible. The gap between the two cell 
populations is simply due to the particular inclination of the plane of section.  A 
blood vessel (V) is found in proximity to the small cell cluster. Scale bar: 0.5 mm. 
 
Fig.  2 
The PV1 in dark-field and cresyl violet stained sections 
A: Dark-field image of the lateral hypothalamus. The PV1-nucleus is lodged 
within a bundle of myelinated nerve fibers, which lies dorsal to the supraoptic 
commissure and the optic tract (ot).  
B: Bright-field images of the lateral hypothalamus (stained with cresyl violet). The 
PV1-nucleus is revealed as a cell-poor region, most of the neurons being located 
between the myelinated fibers. Scale bar: 0.25 mm. 
 
Fig. 3 A and 3B 
The PV1- nucleus on coronal sections 
A-F (left): schematic representations and A’-F’ (right): light micrographs of the 
PV1-nucleus, as seen in a series of 6 coronal sections with a spacing of 
approximately 200 Pm. The PV-immunoreactive cell-cluster is located in the 
LHVL1 that is described by (Geeraedts et al., 1990b), and precisely coincides 
with their “subnucleus-2” at level T11 in their cross section (corresponds to level 
D of this figure). In B’-F’, the PV1-nucleus is encircled, and is represented at 
higher magnifications in the insets. Note differences in the numerical density of 
the PV-immunoreactive cells at the different levels. In its most anterior part the 
PV1-nucleus is intimately associated with the optic tract and lies along the medial 
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edge of this nerve-fibre bundle (B’, E’). In its most caudal part, the PV1-nucleus 
is exposed and sometimes bulges at the lower surface of the brain ( F’). In the 
insets B’, and E’ profiles of vessels are seen along the periphery or crossing the 
PV1-nucleus. The schemes have been reproduced with modifications from 
(Geeraedts et al., 1990a; Geeraedts et al., 1990b). See list of abbreviations 
Scale bar: 1 mm. 
 
Fig. 4 
Confocal laser-scanning microscopy of PV-positive neurons 
PV-immunoreactive neurons (A) and DAPI-stained cell nuclei (B) in the PV1-
nucleus. The nuclei of the PV-immunoreactive nerve cells are chromatin-poor 
and harbor a distinct nucleolus. PV-positive endings terminate on the perikarya 
and on the dendrites (lines ending in a circle) of PV-immunoreactive cells. 
Parvalbumin-positive endings encroach on the surface of three adjacent, 
parvalbumin negative cells bodies (C, arrows) with typical neuronal nuclei (D, 
arrows).  Scale bar: 20 Pm 
 
Fig. 5 
PV1 lacks neurotransmitters and neuromodulators positive cell bodies  
Immunolabelling for four different neuropeptides and two cathecholamines in the 
lateral hypothalamus. The absence of MCH- (A), neurotensin (NT: B), galanin 
(Gal: C) expressing neurons from the PV1-nucleus is striking. The numerical 
densities of NPY-(D) and 5HT-positive (F) fibers and endings are extremely low. 
The PV1-nucleus is particularly rich in TH-positive fibers. Note the presence of a 
small blood vessel along the periphery of the PV1-nucleus (in A, B and C). See 
also list of abbreviations.Scale bar: 0.3 mm. 
 
Fig. 6 
Parvalbumin cells of the PV1-nucleus are positive for glutamate and 
negative for other calcium binding proteins and hypocretin / orexin 
ht
tp
://
do
c.
re
ro
.c
h
25
Neurons of the PV1-nucleus manifest immunoreactivity for both glutamate (A) 
and PV (B), as is evident in the merged image (C: yellow coloration represents 
dual labeling).  Hypocretin/orexin perikarya are scattered in close proximity to the 
PV1, send terminals between parvalbumin positive neurons, but never coexist 
with parvalbumin in the same neuron (D). Cells positive for calbindin D-28k (E) 
and calretinin (F) are sometimes found inside the perimeter of the PV1 as 
defined with PV-antibodies, but no coexistence can be observed. R: rostral, M: 
medial, L: lateral. Scale bar for A, B and C 50 Pm. Scale bar for D, E and F: 100 
Pm. 
The perineuronal net of extracellular matrix is observed around the cell body of 
large parvalbumin neurons of the PV1 (G). Scale bar: 50 Pm. 
Blood vessel arborisation in close proximity to the rostral part of the PV1 (H). 
Scale bar: 0.5 mm 
 
 
Fig. 7 
Transmission electron micrographs of axon terminals in the PV1-nucleus.  
Both probable Gray type II (A and B; inhibitory) and type I (C, D and E; 
excitatory) synapses impinge on the surface of parvalbumin-positive dendrites 
(PV-d). Some synapses cannot be classified. Terminals impinging on PV-
immunoreactive profiles in the PV1-nucleus can be either PV-negative (A-E) or 
PV-positive (PV+t); F). Scale bars in A, C and D: 0.1 Pm; in B: 0.05 Pm; in E and 
F: 0.2 Pm. 
 
Fig. 8 
Three-dimensional reconstruction of the PV1-nucleus from serial coronal 
sections.  
In the rat, the PV1-nucleus (red string) is represented as a long, slender 
accumulation of PV-immunoreactive cells in the lateral hypothalamus. Near its 
centre, the nucleus bends slightly ventrally. The PV1-nucleus is intimately 
associated with the optic tract (ot), the internal capsule (yellow) and the lower 
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surface of the brain. In the mouse, the PV1-nucleus has a more cucumber-like 
form (not shown). See also list of abbreviations. Scale bar: 1 mm. 
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Table 1: Location of the PV1-nucleus in rats and mice 
Species Rat (Wistar, 300 g) Mouse (C57/Bl6, 25 g) 
 Anterior Posterior Anterior Posterior 
Anteroposterior -2.04 -4.16 -1.15 -2.18 
Lateral +/- 2.2 +/- 2.0 +/- 1.4 +/- 1.1 
Depth 8.8 8.8 4.8 4.8 
 
Legend to Table 1: Coordinates of the PV1-nucleus in rats and mice. The values 
are derived from the atlas of Paxinos and Watson (Paxinos and Watson, 1999; 
Paxinos and Watson, 2009) 
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Table 2: Antibodies used in this study 
Antibodies and antisera 
 
Immunogen Producer or catalogue 
and lot no. 
Clonality and dilution 
GAD 67 
(Gamma-amino-
decarboxylase) 
Recombinant GAD 67 protein Chemicon 
Cat. no. AB5992 (clone 
1g10.2) and Dr. W. Oertel 
(Oertel et al., 1981) 
Mouse monoclonal and goat polyclonal 
1:1’000 to 1:3’000 
Parvalbumin 
 
Purified carp PV (235); purified 
rat PV (PV28 and PVG 214) 
Swant 
235, PV28, PVG214 
Mono- and rabbit + goat polyclonals 
1:5’000 to 1: 20’000 
Calbindin D-28k 
 
Calbindin D-28k purified from 
chicken gut (300) and 
recombinant rat calbindin D-28k 
(CB 38) 
Swant 
300, CB38 
Mono and rabbit polyclonal 
1:5’000 to 1: 20’000 
Calretinin 
 
Recombinant human calretinin Swant 
6B3, CR7699 
Mono- and rabbit polyclonal 
1:5’000 to 1: 20’000 
GABA 
 
GABA-glutaraldehyde-bovine 
serum albumin 
Swant 
3D5 and 3A12 
Monoclonals 
1:500 
Glutamate 
 
Glutamate-glutaraldehyde-
bovine serum albumin 
Swant 
2D7 
Monoclonal 
1:500 
Orexin A and B 
 
Synthetic peptide Phoenix Pharmaceuticals 
H-003-30 and H-003-32 
Polyclonal (rabbit) 
1:1’000 
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Legend to Table 2: Antibodies utilized in this study. Some commercial antibodies have been characterized in scientific 
publications (e.g., those sold by Swant Inc.) information respecting which accompanies the company’s description of the 
product.  
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